ArticleBMC cancer2022

TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway.

Dahai Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.